Rendering

Component: (Network and Table)
Network
2409403 - Disclosure - Income Taxes - Summary of Significant Components of Company's Net Deferred Income Tax Assets (Details)
(http://www.aeriepharma.com/role/IncomeTaxesSummaryOfSignificantComponentsOfCompanysNetDeferredIncomeTaxAssetsDetails)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001337553 (http://www.sec.gov/CIK)
Income Tax Disclosure [Abstract]Period [Axis]
2016-12-31
2015-12-31
Income Tax Disclosure [Abstract]
 
 
Net deferred tax assets:
 
 
Net operating loss carry-forwards
39,188,000  
6,335,000  
Share based compensation
11,845,000  
7,231,000  
U.S. tax credit carry-forwards
4,566,000  
3,823,000  
Other assets
1,998,000  
1,488,000  
Other liabilities
(860,000) 
(696,000) 
Valuation allowance
(56,737,000) 
(18,181,000) 
Total net deferred income taxes
0  
 
0